Volume 26, Number 3—March 2020
CME ACTIVITY - Synopsis
Clinical Characteristics of Disseminated Strongyloidiasis, Japan, 1975–2017
Table 1
Demographic characteristics of patients with disseminated strongyloidiasis, Okinawa Chubu Hospital, Uruma, Japan, 1975–2017*
Characteristic | All patients |
Dissemination |
Occult dissemination with meningitis/enteric organisms |
Occult dissemination with culture-negative suppurative meningitis |
||||
---|---|---|---|---|---|---|---|---|
No. patients |
70/70 (100) |
32/70 (45.7) |
12/70 (17.1) |
26/70 (37.1) |
||||
Sex | ||||||||
M | 42 (60) | 19 (59.4) | 6 (50) | 17 (65.3) | ||||
F |
28 (40) |
13 (40.6) |
6 (50) |
9 (34.7) |
||||
Median age, y (range) |
61 (21–96) |
67 (25–96) |
47 (21–84) |
57 (38–92) |
||||
Immunocompromised status | ||||||||
HTLV-1 infection† | 36/40 (90.0) | 17/20 (85.0) | 8/9 (88.9) | 11/11 (100) | ||||
Steroid use | 6 (8.6) | 5 (15.6) | 1 (8.3) | 0 (0) | ||||
Solid organ malignancy | 6 (8.6) | 4 (12.5) | 2 (16.7) | 0 (0) | ||||
Diabetes mellitus | 4 (5.7) | 4 (12.5) | 0 (0) | 0 (0) | ||||
Cirrhosis |
2 (2.9) |
2 (6.3) |
0 (0) |
0 (0) |
||||
Death | 23 (32.9) |
18 (56.3) |
2 (16.7) |
3 (11.5) |
*Values are no. (%) unless indicated. HTLV-1, human T-cell lymphotrophic virus type 1.
†Serologic test for HTLV-1 infection was not available until the 1980s.